About Panacea Medical
Panacea Medical is a company based in Kolar (India) founded in 1999 by Raghu Padmanabhan and G V Subrahmanyam. Panacea Medical has raised $15.37 million across 5 funding rounds from investors including NEA, Tara Fund and Claypond Capital. The company has 373 employees as of April 09, 2024. Panacea Medical offers products and services including Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis. Panacea Medical operates in a competitive market with competitors including Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others.
- Headquarter Kolar, India
- Employees 373 as on 09 Apr, 2024
- Founders Raghu Padmanabhan, G V Subrahmanyam
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Panacea Medical Technologies Private Limited
- Date of Incorporation 26 Mar, 1999
- Jurisdiction Malur, Karnataka, India
-
Annual Revenue
$11.5 M (USD)13.99as on Mar 31, 2024
-
Net Profit
$659.02 K (USD)-30.01as on Mar 31, 2024
-
EBITDA
$2.98 M (USD)23.51as on Mar 31, 2024
-
Total Equity Funding
$15.37 M (USD)
in 5 rounds
-
Latest Funding Round
$5.8 M (USD), Series B
Jan 02, 2025
-
Investors
NEA
& 2 more
-
Employee Count
373
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Panacea Medical
Panacea Medical offers a comprehensive portfolio of products and services, including Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis.
Provides radiation therapy for oncology treatments
Offers advanced cobalt therapy for cancer care
Enables digital imaging for women's health diagnostics
Delivers precise radiation for tumor treatment
Supports detailed mammography for early detection
People of Panacea Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Panacea Medical
Panacea Medical has successfully raised a total of $15.37M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $5.8 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Panacea Medical
Panacea Medical has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NEA, Tara Fund and Claypond Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Single family office of Ranjan Pai, chairman of the Manipal Education and Medical Group
|
Locked | Locked | Locked | |
|
An investment management firm providing strategic financial solutions.
|
Locked | Locked | Locked |
Investor details for Panacea Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Panacea Medical
Investment portfolio details for Panacea Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Panacea Medical
Detailed financials for Panacea Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Panacea Medical Comparisons
Peer comparison for Panacea Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Panacea Medical
Panacea Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of 4D imaging sensors for cancer detection and other devices
|
|
| Locked | Locked | Locked |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| Locked | Locked | Locked |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| Locked | Locked | Locked |
Non-invasive devices for breast and cervical cancer screening are provided.
|
|
| Locked | Locked | Locked |
High-resolution PET scanners for breast imaging are developed and manufactured.
|
|
| Locked | Locked | Locked |
Intraoperative cancer detection devices are developed for real-time tissue assessment.
|
Detailed competitors of Panacea Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Panacea Medical
Complete news archive for Panacea Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panacea Medical
Panacea Medical was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Panacea Medical is headquartered in Kolar, India. It is registered at Kolar, Karnataka, India.
Raghu Padmanabhan is the current CEO of Panacea Medical. They have also founded this company.
Panacea Medical is a funded company, having raised a total of $15.37M across 5 funding rounds to date.
As of Apr 09, 2024, the latest employee count at Panacea Medical is 373.
Annual revenue of Panacea Medical is $11.5M as on Mar 31, 2024.
Panacea was founded in 1999 and is located in Kolar, India, within the medical devices sector. Radiotherapy equipment, including gamma therapy units Bhabhatron MLC and Bhabhatron 3, is manufactured. An advanced simulator called Imagin is produced, alongside Siddharth II for stereotactic imaging and Impact for patient immobilization. Mammography systems such as Lilac 2DC, Lilac 2DD, and Lilac are also developed for diagnostic applications.
Panacea Medical's top competitors include CairnSurgical, Niramai and UE LifeSciences.
Panacea Medical offers Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis.
Panacea Medical has 3 investors. Key investors include NEA, Tara Fund, and Claypond Capital.
The valuation of Panacea Medical is $76.26M as of Jan 2025.